Emerging drugs for antipsychotic-induced tardive dyskinesia: investigational drugs in Phase II and Phase III clinical trials
JT Lockwood, G Remington - Expert Opinion on Emerging Drugs, 2015 - Taylor & Francis
Introduction: Antipsychotic drugs (APs) represent the mainstay of treatment for schizophrenia
and other forms of psychosis. Tardive dyskinesia (TD) is a motor disorder associated with …
and other forms of psychosis. Tardive dyskinesia (TD) is a motor disorder associated with …
Subjective awareness of tardive dyskinesia and insight in schizophrenia
R Emsley, DJH Niehaus, PP Oosthuizen, L Koen… - European …, 2011 - cambridge.org
BackgroundLack of awareness of tardive dyskinesia (TD) and poor insight into mental
illness are common in schizophrenia, raising the possibility that these phenomena are …
illness are common in schizophrenia, raising the possibility that these phenomena are …
Polyunsaturated fatty acids in emerging psychosis
N Mossaheb, M Schloegelhofer… - Current …, 2012 - ingentaconnect.com
The role of polyunsaturated fatty acids and their metabolites for the cause and treatment of
psychotic disorders are widely discussed. The efficacy as an augmenting agent in chronic …
psychotic disorders are widely discussed. The efficacy as an augmenting agent in chronic …
Nutrition in the Treatment of Schizophrenia: Rationale and Review of Recent Evidence
SS Kulaga, DL Kelly - Current Behavioral Neuroscience Reports, 2023 - Springer
Abstract Purpose of Review This review aims to provide an overview of the
pathophysiological basis for the use of nutritional strategies in the treatment of …
pathophysiological basis for the use of nutritional strategies in the treatment of …
Efficacy and safety of different pharmacological interventions in the treatment of tardive dyskinesia: a systematic review and network meta-analysis
O Ismail, K Albdour, Y Jaber, K Jaber… - European Journal of …, 2024 - Springer
Objectives The aim of this study is to indirectly compare and rank the different drugs that
have been studied in randomized clinical trials (RCTs) in patients with tardive dyskinesia …
have been studied in randomized clinical trials (RCTs) in patients with tardive dyskinesia …
Are omega-3 fatty acids efficacious in the treatment of depression? A review
K Lange, Y Nakamura, H Zhao, D Bai… - Journal of Food …, 2021 - isnff-jfb.com
The hypothesis that omega-3 fatty acids may play a role in preventing and treating
depression is based on correlative associations between fish consumption, omega-3 fatty …
depression is based on correlative associations between fish consumption, omega-3 fatty …
Changes in erythrocyte membrane fatty acids during a clinical trial of eicosapentaenoic acid (EPA) supplementation in schizophrenia
SJ van Rensburg, CM Smuts, D Hon, M Kidd… - Metabolic brain …, 2009 - Springer
In a previously reported double-blind, placebo-controlled trial of eicosapentaenoic acid
(EPA) as supplemental treatment in 40 patients with schizophrenia, we found significant …
(EPA) as supplemental treatment in 40 patients with schizophrenia, we found significant …
Omega-3 fatty acids in cause, prevention and management of violence in schizophrenia: Conceptualization and application
WC Ouyang, GC Sun, MC Hsu - Aggression and violent behavior, 2020 - Elsevier
Schizophrenia is a disabling neurological disorder. Patients with this disease are at higher
risk to violence. This paper reviewed the recent literatures with respect to the heterogeneous …
risk to violence. This paper reviewed the recent literatures with respect to the heterogeneous …
Assessment of the efficacy of omega-3 fatty acids on metabolic and inflammatory parameters in patients with schizophrenia taking clozapine and sodium valproate
Abstract Omega-3 fatty acid (FA) supplementation has been reported to improve several
cardio-metabolic risk factors. We aimed to assess the efficacy of omega-3 fatty acids on …
cardio-metabolic risk factors. We aimed to assess the efficacy of omega-3 fatty acids on …
Longitudinal investigation of the relationship between omega-3 polyunsaturated fatty acids and neuropsychological functioning in recent-onset psychosis: a …
PR Szeszko, RK McNamara, JA Gallego… - Schizophrenia …, 2021 - Elsevier
Alterations in polyunsaturated fatty acids (PUFAs), including omega-3 and omega-6, have
been implicated in the pathophysiology of psychotic disorders, but little is known about their …
been implicated in the pathophysiology of psychotic disorders, but little is known about their …